Fig. 1
From: Investigating resistin like beta (RETNLB) as a tumor promoter for oral squamous cell carcinoma
Expression of RETNLB and survival curve. (a) Expression of RETNLB in oral squamous cell carcinoma tissues and the adjacent non-tumor tissues was evaluated according to The Cancer Genome Atlas database. (b) Expression of RETNLB in oral squamous cell carcinoma cell lines (TCA-83 and CAL27) and normal cell line HOEC was identified by real-time qPCR. **p < 0.01 vs. HOEC group. Data are presented as means ± standard deviation. Columns, means. Bars, standard deviations. (c) Overall survival curve of oral squamous cell carcinoma patients with high and low RETNLB expression was plotted by Kaplan-Meier method. High RETNLB expression vs. low RETNLB expression. The median overall survival and 95% confidence interval (CI) of RETNLB low expression group were 7.041 and 2.047–12.035, respectively. The median overall survival and 95% CI of RETNLB high expression group were 2.956 and 2.042–3.870, respectively